Northwestern Mutual Wealth Management
GNMX

Northwestern Mutual Wealth Management’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-10,000
Closed -$20K – 2557
2018
Q1 		$20K Hold
10,000
– – ﹤0.01% 1547
2017
Q4 		$12K Buy
+10,000
New +$13.7K ﹤0.01% 1707
2017
Q1 		– Sell
-200
Closed -$1K – 2559
2016
Q4 		$1K Buy
+200
New +$1.05K ﹤0.01% 2305

Other funds holding GNMX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Northwestern Mutual Wealth Management's GNMX Position: Q2 2018 in Review

Northwestern Mutual Wealth Management sold out of Aevi Genomic Medicine Inc (GNMX) in Q2 2018, closing a stake of 10,000 shares — an estimated $20K sold.

Northwestern Mutual Wealth Management first reported a position in GNMX in Q4 2016 and held it in 3 quarters. The position peaked at $20K in Q1 2018. 40 funds tracked by Wall St. Rank hold GNMX as of Q2 2018.

  • Northwestern Mutual Wealth Management reported no remaining Aevi Genomic Medicine Inc position as of Q2 2018 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 10,000 Aevi Genomic Medicine Inc shares in Q2 2018, an estimated $20K.
  • Northwestern Mutual Wealth Management first reported a position in Aevi Genomic Medicine Inc in Q4 2016 and held it in 3 quarters.
  • Northwestern Mutual Wealth Management's Aevi Genomic Medicine Inc position peaked at $20K in Q1 2018.
  • 40 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q2 2018.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2018, filed 10 Aug 2018.